Green Plains Inc (GPRE) concluded trading on Thursday at a closing price of $6.54, with 4.37 million shares of worth about $28.61 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -53.98% during that period and on February 13, 2025 the price saw a gain of about 4.98%. Currently the company’s common shares owned by public are about 64.71M shares, out of which, 63.13M shares are available for trading.
Stock saw a price change of -21.11% in past 5 days and over the past one month there was a price change of -28.52%. Year-to-date (YTD), GPRE shares are showing a performance of -31.01% which decreased to -73.43% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.98 but also hit the highest price of $24.21 during that period. The average intraday trading volume for Green Plains Inc shares is 1.37 million. The stock is currently trading -22.91% below its 20-day simple moving average (SMA20), while that difference is down -30.39% for SMA50 and it goes to -51.27% lower than SMA200.
Green Plains Inc (NASDAQ: GPRE) currently have 64.71M outstanding shares and institutions hold larger chunk of about 103.04% of that.
The stock has a current market capitalization of $423.33M and its 3Y-monthly beta is at 1.52. It has posted earnings per share of -$1.38 in the same period. It has Quick Ratio of 0.89 while making debt-to-equity ratio of 0.75. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GPRE, volatility over the week remained 13.98% while standing at 7.16% over the month.
Stock’s fiscal year EPS is expected to rise by 63.02% while it is estimated to increase by 249.02% in next year.
Coverage by BofA Securities stated Green Plains Inc (GPRE) stock as a Buy in their note to investors on May 12, 2023, suggesting a price target of $39 for the stock. On April 14, 2023, BMO Capital Markets Resumed their recommendations, while on January 17, 2023, Stephens Downgrade their ratings for the stock with a price target of $37. Stock get a Buy rating from UBS on December 14, 2022.
